Barinthus Biotherapeutics (BRNS) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Barinthus Biotherapeutics (BRNS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | 15M | - | - | - | - | 330K (-29.79%) | 470K (-92.72%) | 6.46M (+4.70%) | 6.17M (-63.83%) | 17M (+13.58%) | 15M | - | 20K (-50.00%) | 40K (-81.82%) | 220K (-37.14%) | 350K (-89.23%) | 3.25M (+537.25%) | 510K (-28.17%) | 710K |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 3.59M (-8.65%) | 3.93M (-27.09%) | 5.39M (-32.20%) | 7.95M (-4.10%) | 8.29M (-0.24%) | 8.31M (-25.40%) | 11M (-4.46%) | 12M (+4.76%) | 11M (+74.73%) | 6.37M (-57.93%) | 15M (+11.82%) | 14M (+38.02%) | 9.81M (-19.52%) | 12M (+25.15%) | 9.74M (+0.21%) | 9.72M (-9.16%) | 11M (+55.52%) | 6.88M (+57.44%) | 4.37M (-3.10%) | 4.51M (-2.17%) | 4.61M (+79.38%) | 2.57M (-30.54%) | 3.70M (-4.64%) | 3.88M (-8.49%) | 4.24M |
Selling General And Administrative | 2.53M (-66.88%) | 7.64M (+47.78%) | 5.17M (-66.38%) | 15M (+21.68%) | 13M (+313.07%) | 3.06M (-77.20%) | 13M (+86.39%) | 7.20M (+20.20%) | 5.99M (-56.02%) | 14M (+1318.75%) | 960K (-92.69%) | 13M (+8.15%) | 12M (+344.69%) | 2.73M | - | - | 3.66M (-62.61%) | 9.79M (+729.66%) | 1.18M (-90.46%) | 12M (+594.94%) | 1.78M (-76.01%) | 7.42M (+657.14%) | 980K (+1.03%) | 970K (-12.61%) | 1.11M |
Operating Expenses | 6.12M (-47.10%) | 12M (-23.98%) | 15M (-34.79%) | 23M (+11.51%) | 21M (-11.20%) | 24M (-4.03%) | 25M (+30.22%) | 19M (+10.16%) | 17M (-14.36%) | 20M (+24.08%) | 16M (-39.60%) | 27M (+21.50%) | 22M (-30.58%) | 32M | -1.07M | 3.83M (-73.33%) | 14M (-13.86%) | 17M (+199.82%) | 5.56M (-67.06%) | 17M (+164.16%) | 6.39M (-36.04%) | 9.99M (+113.46%) | 4.68M (-3.51%) | 4.85M (-9.35%) | 5.35M |
Depreciation And Amortization | 860K (-65.74%) | 2.51M (+2410.00%) | 100K (-91.67%) | 1.20M (-40.89%) | 2.03M (-31.65%) | 2.97M (+324.29%) | 700K (0.00%) | 700K (-51.05%) | 1.43M (-52.49%) | 3.01M (+330.00%) | 700K (+40.00%) | 500K (-59.02%) | 1.22M (-55.80%) | 2.76M (+590.00%) | 400K (+100.00%) | 200K (-79.38%) | 970K (+90.20%) | 510K | - | - | 90K (-43.75%) | 160K | - | - | 50K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -6.07M (-47.49%) | -11.56M (-23.29%) | -15.07M (-35.38%) | -23.32M (+13.20%) | -20.60M (-11.93%) | -23.39M (+149.36%) | -9.38M (-48.72%) | -18.29M (+8.16%) | -16.91M (-15.41%) | -19.99M (+24.16%) | -16.10M (-38.88%) | -26.34M (+22.63%) | -21.48M (-14.66%) | -25.17M | 7.24M (-45.32%) | 13M (+1936.92%) | 650K | -16.67M (+200.90%) | -5.54M (-67.10%) | -16.84M (+172.93%) | -6.17M (-35.93%) | -9.63M (+573.43%) | -1.43M (-67.05%) | -4.34M (-6.67%) | -4.65M |
Ebit | -6.07M (-47.49%) | -11.56M (-23.29%) | -15.07M (-35.38%) | -23.32M (+13.20%) | -20.60M (-11.93%) | -23.39M (+149.36%) | -9.38M (-48.72%) | -18.29M (+8.16%) | -16.91M (-15.41%) | -19.99M (+24.16%) | -16.10M (-38.88%) | -26.34M (+22.63%) | -21.48M (-14.66%) | -25.17M | 7.24M (-45.32%) | 13M (+1936.92%) | 650K | -16.67M (+200.90%) | -5.54M (-67.10%) | -16.84M (+172.93%) | -6.17M (-35.93%) | -9.63M (+573.43%) | -1.43M (-67.05%) | -4.34M (-6.67%) | -4.65M |
EBITDA | -5.22M (-42.32%) | -9.05M (-39.55%) | -14.97M (-32.32%) | -22.12M (+19.12%) | -18.57M (-9.06%) | -20.42M (+135.25%) | -8.68M (-50.65%) | -17.59M (+13.63%) | -15.48M (-8.83%) | -16.98M (+10.26%) | -15.40M (-40.40%) | -25.84M (+27.54%) | -20.26M (-9.59%) | -22.41M | 7.64M (-43.15%) | 13M (+729.63%) | 1.62M | -18.06M (+296.05%) | -4.56M (-71.34%) | -15.91M (+161.68%) | -6.08M (-52.43%) | -12.78M | 1.13M | -3.59M (-21.96%) | -4.60M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 350K (-14.63%) | 410K (-12.77%) | 470K (-9.62%) | 520K (-7.14%) | 560K (-12.50%) | 640K (+1.59%) | 630K (-1.56%) | 640K (-17.95%) | 780K (+36.84%) | 570K (+185.00%) | 200K (-61.54%) | 520K (-67.30%) | 1.59M (+19.55%) | 1.33M (+30.39%) | 1.02M (+52.24%) | 670K (+737.50%) | 80K | - | - | - | - | - | - | - | - |
Interest Expense | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (+100.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | -50.00K | - | - | 70K (+250.00%) | 20K | - | - | 2.65M (+0.76%) | 2.63M (+171.13%) | 970K | - | - |
Net Interest Income | 350K (-14.63%) | 410K (-12.77%) | 470K (-9.62%) | 520K (-7.14%) | 560K (-13.85%) | 650K (+3.17%) | 630K (-1.56%) | 640K (-15.79%) | 760K (+40.74%) | 540K (+170.00%) | 200K (-61.54%) | 520K (-67.30%) | 1.59M (+15.22%) | 1.38M (+35.29%) | 1.02M (+52.24%) | 670K (+6600.00%) | 10K | -20.00K | - | - | -2.65M (+0.76%) | -2.63M (+171.13%) | -970.00K | - | - |
Other Non Operating Income | 40K (+100.00%) | 20K | -280.00K | 320K (+300.00%) | 80K (-42.86%) | 140K (+366.67%) | 30K (+50.00%) | 20K | - | 1.08M | - | 310K (-88.73%) | 2.75M (+382.46%) | 570K (+83.87%) | 310K (+520.00%) | 50K (-95.28%) | 1.06M (+221.21%) | 330K (-65.63%) | 960K | - | -9.28M | 40K (-97.55%) | 1.63M (+139.71%) | 680K (-2.86%) | 700K |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -5.55M (-50.27%) | -11.16M (-23.77%) | -14.64M (-30.78%) | -21.15M (+7.47%) | -19.68M (-4.42%) | -20.59M (+153.26%) | -8.13M (-52.04%) | -16.95M (+8.93%) | -15.56M (-14.08%) | -18.11M (+23.11%) | -14.71M (-41.07%) | -24.96M (+33.19%) | -18.74M (-19.15%) | -23.18M | 7.55M (-48.88%) | 15M (+763.74%) | 1.71M | -51.14M | - | - | - | - | - | - | - |
Income Tax Expense | -20.00K (-66.67%) | -60.00K (-14.29%) | -70.00K (+250.00%) | -20.00K (0.00%) | -20.00K | - | - | -10.00K (-75.00%) | -40.00K (-95.12%) | -820.00K (+36.67%) | -600.00K (-47.37%) | -1.14M (+119.23%) | -520.00K (-74.26%) | -2.02M (+201.49%) | -670.00K (-26.37%) | -910.00K (+5.81%) | -860.00K | 30K | -10.00K | 10K | -60.00K | 100K | - | - | - |
Net Income From Continuing Operations | -5.53M (-50.14%) | -11.09M (-23.88%) | -14.57M (-31.01%) | -21.12M (+7.48%) | -19.65M (-4.33%) | -20.54M (+153.27%) | -8.11M (-52.10%) | -16.93M (+9.30%) | -15.49M (-10.41%) | -17.29M (+22.89%) | -14.07M (-40.88%) | -23.80M (+30.91%) | -18.18M (-14.20%) | -21.19M | 8.24M (-47.48%) | 16M (+503.46%) | 2.60M | -15.11M (+231.36%) | -4.56M (-71.37%) | -15.93M (+4.32%) | -15.27M (+46.12%) | -10.45M | 160K | -3.59M (-6.02%) | -3.82M |
Net Income | -5.53M (-50.14%) | -11.09M (-23.88%) | -14.57M (-31.01%) | -21.12M (+7.48%) | -19.65M (-4.33%) | -20.54M (+153.27%) | -8.11M (-52.10%) | -16.93M (+9.30%) | -15.49M (-10.41%) | -17.29M (+22.89%) | -14.07M (-40.88%) | -23.80M (+30.91%) | -18.18M (-14.20%) | -21.19M | 8.24M (-47.48%) | 16M (+503.46%) | 2.60M | -15.11M (+231.36%) | -4.56M (-71.37%) | -15.93M (+4.32%) | -15.27M (+46.12%) | -10.45M | 160K | -3.59M (-6.02%) | -3.82M |
Comprehensive Income Net Of Tax | -8.36M (-85.15%) | -56.29M (+221.66%) | -17.50M (+36.29%) | -12.84M (-14.40%) | -15.00M (-76.43%) | -63.63M | 1.07M | -16.77M (-1.76%) | -17.07M (-72.99%) | -63.20M (+188.85%) | -21.88M (+20.22%) | -18.20M (+33.73%) | -13.61M (-30.67%) | -19.63M (+68.21%) | -11.67M (+980.56%) | -1.08M (-67.95%) | -3.37M (-94.20%) | -58.11M (+427.31%) | -11.02M (-30.43%) | -15.84M (-5.09%) | -16.69M (-9.69%) | -18.48M | 220K | -3.73M (-16.93%) | -4.49M |